Konijnenberg, Mark
Herrmann, Ken
Kobe, Carsten
Verburg, Frederik
Hindorf, Cecilia
Hustinx, Roland
Lassmann, Michael http://orcid.org/0000-0002-2556-1977
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 5 June 2020
Accepted: 11 September 2020
First Online: 15 October 2020
Compliance with ethical standards
:
: MK declares that he has nothing to disclose. He is chair of the EANM Dosimetry Committee.KH reports personal fees from Bayer, stock options (< 1%) from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis and personal fees from ymabs outside the submitted work. He is chair of the EANM Oncology Committee.CK declares that he has nothing to disclose. He is member of the EANM Oncology Committee.FAV has received consultancy fees from Jubilant Draximage, EISAI and Sanofi as well as speaker honoraria from Sanofi. He is member of the EANM Thyroid Committee.CH declares that she has no conflict of interest. She is member of the EANM Physics Committee.RH declares that he has nothing to disclose. He is member of the EANM Board.ML has received research grants by IPSEN Pharma and Nordic Nanovector. He is member of the EANM Board.
: This article does not contain any studies with human participants or animals performed by any of the authors.